Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Comparing adherence rates to disease modifying therapies for multiple sclerosis in commercial enrollees and Part D beneficiaries.
Highlights From the 2014 Joint Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)-European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS).
Erratum to: Fingolimod in the treatment algorithm of relapsing remitting multiple sclerosis: a statement of the Central and East European (CEE) MS Expert Group.
Acute sensory neuropathy: 2 year follow-up of sensory conduction.
[Prognostic factors of multiple sclerosis in children and adolescents after the first demyelinating event.]
Development and aging of superficial white matter myelin from young adulthood to old age: Mapping by vertex-based surface statistics (VBSS).
Candidate SNP Markers of Gender-Biased Autoimmune Complications of Monogenic Diseases Are Predicted by a Significant Change in the Affinity of TATA-Binding Protein for Human Gene Promoters.
HERV-W polymorphism in chromosome X is associated with multiple sclerosis risk and with differential expression of MSRV.
A case of fulminant neuromyelitis optica presenting with destructive lesions in whole-brain.
Serum analysis by 1H Nuclear Magnetic Resonance spectroscopy: a new tool for distinguishing neuromyelitis optica from multiple sclerosis.
Gamma Knife rhizotomy-induced histopathology in multiple sclerosis-related trigeminal neuralgia.
Evaluation of clinical parameters during and after treatment of attack in patients with clinically isolated syndrome: Comparison of the results with that of multiple sclerosis patients.
Teriflunomide in relapsing multiple sclerosis: therapeutic utility.
Lesion length of optic neuritis impacts visual prognosis in neuromyelitis optica.
Optimizing JC and BK polyomavirus IgG testing for seroepidemiology and patient counseling.
Changes in brain functional connectivity patterns are driven by an individual lesion in MS: a resting-state fMRI study.
Minimal clinically important difference for change in comfortable gait speed of adults with pathology: a systematic review.
Guidelines from The Italian Neurological and Neuroradiological Societies for the use of magnetic resonance imaging in daily life clinical practice of multiple sclerosis patients.
miFRame: analysis and visualization of miRNA sequencing data in neurological disorders.
Roles of T helper 17 cells and interleukin-17 in neuroautoimmune diseases with emphasis on multiple sclerosis and Guillain-Barré syndrome as well as their animal models.
Computational modeling of cytokine signaling in microglia.
Does low socioeconomic status in early life protect against multiple sclerosis? A multinational, case-control study.
Anti-inflammatory mechanisms of IFN-γ studied in experimental autoimmune encephalomyelitis reveal neutrophils as a potential target in multiple sclerosis.
The Nuclear IκB Family Protein IκBNS Influences the Susceptibility to Experimental Autoimmune Encephalomyelitis in a Murine Model.
Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study.

Pages